- Location
AML
"-
African Mine
Apr 21, 2015State-owned Shandong Iron and Steel Group Co Ltd said on Monday that it has acquired the remaining 75 percent stake it does not own in a mining project in western Africa's Sierra Leone. Shandong Steel had earlier acquired a 25 percent ...
Tags: Steel Firm, Iron Group, Steel Group
-
U.S. Companies Are Crying Foul Over China's Oversight of Monopoly and Pricing Issues
May 26, 2014U.S. companies are crying foul over China’s oversight of monopoly and pricing issues, as antitrust enforcement threatens to further sour Sino-American business ties already damaged by a row over cyber espionage. The U.S. Chamber of ...
-
AML Has Produced a Number of Tried and Tested Label Materials
Feb 25, 2014AM Labels Limited (AML), the labelling, barcoding and software specialist based in Kettering, Northamptonshire, has produced a number of tried and tested label materials, which the company can cut to custom sizes, for use with the new Epson ...
Tags: AM Labels, Tested Label Solution
-
Miltenyi Biotec Receives Approval From FDA for Clinimacs CD34 Reagent System
Feb 10, 2014German biotechnology company Miltenyi Biotec has received the US Food and Drug Administration's(FDA)approval for its CliniMACS CD34 reagent system to prevent graft-versus-host disease(GVHD)in the treatment of acute myeloid leukemia(AML). ...
Tags: Miltenyi Biotec, Blood, Medicine
-
FDA Has Approved Merck's Noxafil 100 Mg Delayed-Release Tablets.
Nov 29, 2013The US Food and Drug Administration (FDA) has approved Merck's Noxafil (posaconazole) 100 mg delayed-release tablets. The tablets are a new formulation with a loading dose of 300mg (three 100mg delayed-release tablets) twice daily on the ...
-
Stemline Therapeutics Announce Their Collaboration to Accelerate The Development of SL-401
Oct 31, 2013Stemline Therapeutics, a clinical stage biopharmaceutical company, and The Leukemia & Lymphoma Society (LLS), a voluntary health organization, have announced their collaboration to accelerate the development of SL-401 for the treatment of ...
-
Cornerstone Pharmaceuticals Has Received The US FDA Orphan Drug Designation
Oct 8, 2013Cornerstone Pharmaceuticals has received the US Food and Drug Administration (FDA) orphan drug designation for its altered energy metabolism directed (AEMD) drug candidate 'CPI-613' for treatment of myelodysplastic syndrome (MDS). MDS is ...
-
Stemline Therapeutics' SL-401 Has Won Orphan Drug Designation From The FDA
Jun 13, 2013Stemline Therapeutics' SL-401 has won orphan drug designation from the Food and Drug Administration (FDA) for the treatment of aggressive hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN). With an orphan drug ...
Tags: Stemline Therapeutic, Orphan Drug
-
GiGse 2013 Will Be Hosted at The Market Street Westin in San Francisco, Calif.
Apr 22, 2013Organizers of the upcoming Global iGaming Summit and Expo (GiGse) announced panel speaker JD Garner, President of GambleID, as a panelist for two of its more anticipated sessions. GiGse 2013 will be hosted at the Market Street Westin in San ...
Tags: Smart Identity, iGaming Summit
-
AML Has Introduced a New Policy to Meet The Insurance Needs
Jan 28, 2013AML Underwriting (AML) has introduced a new policy to meet the insurance needs of restaurants and other similar establishments. Offered through all AML brokers, the new restaurant policy will provide a number of automatic sections and ...
Tags: AML, new policy, insurance needs
-
AML Prefers to Expand Its Existing Rail and Port Infrastructure in Pepel
Dec 24, 2012African Minerals Limited recently disclosed in a regulation filing that it now prefers to expand its existing rail and port infrastructure in Pepel, rather than develop a new port at Tagrin Point. This revised expansion is expected to ...
Tags: AML, African Minerals Limited, regulation, rail, port infrastructure
-
EC Has Granted Orphan Drug Designation to Sunesis Pharmaceuticals' Vosaroxin Drug
Dec 5, 2012The European Commission (EC) has granted orphan drug designation to Sunesis Pharmaceuticals' Vosaroxin drug. Vosaroxin is a first-in-class anti-cancer quinolone derivative, (AQD), used for the treatment of acute myeloid leukemia (AML). ...
Tags: vosaroxin, AQD, AML, anti-cancer quinolone derivative
-
Coronado Biosciences Received Notice of Allowance for CNDO-109
Dec 5, 2012Coronado Biosciences has received notice of allowance for US patent application covering CNDO-109, from the US Patent and Trademark Office (USPTO). The patent is entitled, Method for activating natural killer cells by tumor cell ...
Tags: CNDO-109, cancer cells, AML
-
Oxigene Acute Myelogenous Leukemia Drug Candidate Has Received FDA Orphan Drug Status
Nov 27, 2012Clinical-stage biopharmaceutical company OXiGENE's acute myelogenous leukemia (AML) drug candidate, OXi4503, has received FDA orphan drug status. The second-generation anticancer agent with a dual-mechanism vascular disrupting feature ...
Related Products
-
Felivet Fiv Ab - Felv AG Combo Test Immunodeficiency Disease
-
Felivet Fiv Ab Felv Leukemia Virus AG Combo Test
-
Felivet Fiv Ab - Felv AG Combo Test Acute Myeloid Leukemia Leukemic Leukemia
-
Felivet Fiv Immunodeficiency Ab Felv Acute Myeloid Leukemia AG Combo Test
-
Economical Auto Moment Limiter for Safe Crane Operations
-
Wtl a 200 Crane Lmi Load Monitoring Equipment System for Pipeline Construction
